- Open Access
Characterization of T cell activation and regulation in children with asymptomatic Plasmodium falciparum infection
Malaria Journal volume 17, Article number: 263 (2018)
Asymptomatic Plasmodium infections are characterized by the absence of clinical disease and the ability to restrict parasite replication. Increasing levels of regulatory T cells (Tregs) in Plasmodium falciparum infections have been associated with the risk of developing clinical disease, suggesting that individuals with asymptomatic infections may have reduced Treg frequency. However, the relationship between Tregs, cellular activation and parasite control in asymptomatic malaria remains unclear.
In a cross-sectional study, the levels of Tregs and other T cell activation phenotypes were compared using flow cytometry in symptomatic, asymptomatic and uninfected children before and after stimulation with infected red blood cell lysates (iRBCs). In addition, the association between these T cell phenotypes and parasitaemia were investigated.
In children with asymptomatic infections, levels of Tregs and activated T cells were comparable to those in healthy controls but significantly lower than those in symptomatic children. After iRBC stimulation, levels of Tregs remained lower for asymptomatic versus symptomatic children. In contrast, levels of activated T cells were higher for asymptomatic children. Strikingly, the pre-stimulation levels of two T cell activation phenotypes (CD8+CD69+ and CD8+CD25+CD69+) and the post-stimulation levels of two regulatory phenotypes (CD4+CD25+Foxp3+ and CD8+CD25+Foxp3+) were significantly positively correlated with and explained 68% of the individual variation in parasitaemia. A machine-learning model based on levels of these four phenotypes accurately distinguished between asymptomatic and symptomatic children (sensitivity = 86%, specificity = 94%), suggesting that these phenotypes govern the observed variation in disease status.
Compared to symptomatic P. falciparum infections, in children asymptomatic infections are characterized by lower levels of Tregs and activated T cells, which are associated with lower parasitaemia. The results indicate that T cell regulatory and activation phenotypes govern both parasitaemia and disease status in paediatric malaria in the studied sub-Saharan African population.
Falciparum malaria occurs when sporozoites inoculated into the human host develop in the liver into merozoites that infect red blood cells and cause clinical disease. The acquisition of natural immunity to falciparum malaria is slow and requires frequent exposure to the parasite over a period of time . Despite previous exposure to the parasite, people in endemic areas may remain susceptible to clinical disease or they may be asymptomatic carriers of parasites as clinical immunity is only partial and never sterile. Also, repeated parasite exposure has been associated with limited protectiveness to vaccine candidates [2, 3]. The lack of a proper understanding of the immune responses occurring during natural infections has, for example, resulted in an inability to develop effective interventions such as vaccines.
Understanding the regulatory and protective immune responses during asymptomatic and clinical infections remain necessary to comprehend mechanisms that enable the control of infections as well as the persistence and survival of the parasite. A number of studies in malaria have associated protection from clinical disease with having a broad antibody repertoire [4,5,6]. Nonetheless, the presence of asymptomatic infections in children who may not have a broad antibody repertoire suggests that there is some level of immunity to the parasite by the host and this is characterized by the absence of clinical manifestations of the disease. Moreover, during Plasmodium falciparum infections, it is believed that the effector function of immune cells will be compromised due to immune regulation . This may be induced by the specific expansion of certain T or B cell sub-sets and modulation of certain antigen presenting cells, such as the dendritic cells . T cells express receptors that enable co-stimulation, activation, memory formation, and immune regulation to ensure effective and timely immune response induction upon antigen recognition. The expansion of specific cell sub-sets, especially those that express regulatory markers, may either enhance or inhibit the development of immunity against an infection. However, the association between such cellular activation and regulatory markers and parasite control during asymptomatic infections is inadequately understood.
Regulatory T cells are unique cell phenotypes that function to maintain homeostasis when the immune response is activated. The establishment of immune homeostasis may result in blocking the activity of other immune cells. For instance, CTLA-4 (also known as CD152), once activated, functions to inhibit activation of both antigen presenting cells and other T cells. Even though the role of Tregs during P. falciparum infections remains controversial, it has been observed that in both human and rodent malaria an early induction of Tregs may result in an increased parasite density [9,10,11,12]. Furthermore, the expansion of Tregs in malaria has been associated with decreased antigen-specific immune responses .
Also, a recent study by Kurup et al.  has shown that CTLA-4 Tregs expand during symptomatic malaria in both human and murine models, which is associated with decreased parasite clearance and impedes the acquisition of immunity in murine models. Other studies have also reported the upregulation of TNFRII on Tregs with asymptomatic parasitaemia . There have also been reports on the upregulation of FOXP3 mRNA transcripts during acute malaria infections in children and naïve adults, which negatively correlated with Th1 memory responses [9, 15]. Nonetheless, other studies have also shown conflicting data whereby no association was found between the levels of Tregs and Plasmodium infection [16,17,18,19]. Collectively, these imply that the activity of Tregs associated with the development of protective immunity needs to be comprehended. The likely suggestions are that infections may cause the expansion of Tregs, which in turn may cause immune suppression and enhance parasite growth as observed in other studies [11, 20, 21].
This study aims to compare the expression levels of T cell activation and regulatory markers across symptomatic, asymptomatic and healthy control children living in hyperendemic areas with stable malaria transmission in Ghana. The Treg markers CD25+Foxp3+, the early activation marker CD69, and the late activation marker CD25 were measured. Tregs have an established role in suppressing effector immune responses to a variety of pathogens, including malarial parasites [22, 23]. CD69 expression in CD4+ T cells has been shown to correlate with the development of antigen-specific antibodies in experimental human falciparum malaria . CD69 is a transmembrane glycoprotein expressed during early activation and increases with inflammation with the potential to induce cytotoxic activity once crosslinked [25,26,27,28,29], whereas CD25 (IL-2α receptor) has been associated with T cell proliferation and differentiation through the IL-2 cytokine . This suggests that their combined expression may lead to an enhanced cellular immune activity. Therefore, it was hypothesized that asymptomatic infections have reduced Treg levels, such that exposure to P. falciparum is associated with increased cellular response and lower parasitaemia, which in turn feeds back to reduce cellular activation.
Participants for the study were recruited from Asutsuare and Paakro sub-districts, which are hyperendemic for malaria transmission. Asutsuare has two malaria transmission seasons; June to August (high transmission season) and November to December (low transmission season) with an entomological inoculation rate of 14.6 infective bites/man/year whereas Paakro has May to June as the high transmission season and September to October as the low transmission season [30, 31]. Samples from participants were obtained during the high transmission seasons.
Participants and sample collection
The study was approved by the Institutional Review Board of the Noguchi Memorial Institute for Medical Research, University of Ghana (Permit No. 096/15-16). A written informed consent was obtained from parents or guardians and assent appropriately received from the children before they were enrolled. Samples were obtained in a cross-sectional study from 57 children under 13 years old who satisfied the inclusion criteria with no known conditions that could interfere with the experiments. The participants were grouped into P. falciparum-infected asymptomatic children (n = 18), symptomatic malaria patients (n = 22) and healthy controls (n = 17). About 5 ml of venous blood was collected into heparin tubes before anti-malarial treatment. Both thick and thin smears were prepared and stained with Giemsa for parasite identification after screening for infection with rapid diagnostic tests. Haematological indices were determined by an automated haematological analyzer. PBMCs were isolated by ficoll gradient centrifugation and stored in liquid nitrogen until the time of the experiment. The PBMCs were cryopreserved in fetal bovine serum with 10% dimethyl sulfoxide (DMSO).
Flow cytometry analysis
Stored PBMCs were thawed and washed. The viability was assessed by trypan blue dye exclusion method. Cells with viability greater than 95% were used in the assay. The cells were surface stained with the following antibodies for T cell sub-sets (anti-CD3, anti-CD4, anti-CD8), co-stimulation markers (anti-CD28, anti-CD57) and activation markers (anti-CD25, anti-CD69) (Additional file 1). The cells were washed, fixed and permeabilized using FOXP3 buffer set (BD) and intracellularly stained for regulatory markers Foxp3 (Biolegend) and CTLA-4 (BD). Fluorescence minus one controls and compensation were performed to set gates using single colour stained or unstained PBMCs. Data were compensated and analysed using Flowjo V10 software (Tree Star, San Carlos, CA, USA). The gating strategies are outlined in Figs. 1a and 2a.
Stimulation of PBMCs with infected and uninfected red blood cells
Plasmodium falciparum parasites of the NF54 strain were cultured in O+ red blood cells at 3% haematocrit in culture medium (RPMI 1640 medium, 25 µg/ml of gentamycin, 10% heat-inactivated O+ human serum). The culturing was done in the presence of 7.5% sodium bicarbonate at 37 °C in a 5% O2, 5% CO2 and 90% N2 atmosphere. PBMCs were later thawed and rested for 6 h in 10% fetal bovine serum. About 400,000 cells were later stimulated with intact P. falciparum trophozoites/schizont (NF54 clone)-infected RBCs (iRBCs; 3 iRBCs: 1 PBMC) or uninfected RBCs (uRBCs; 3 uRBCs: 1 PBMC) and cultured in complete RPMI 1640 in 5% CO2 at 37 °C. After 4 h of stimulation, brefeldin A was added at a concentration of 10 µg/ml. Cells were washed and stained after 18 h with the following monoclonal antibodies; anti-CD3 (APC-H7), CD4 (BUV 395), CD8 (PerCP-Cy5.5), CD25 (PE-CF594), CD69 (PE-Cy7), CD152/CTLA-4 (APC), FOXP3 (PE) all from BD. The cells were washed by centrifugation before staining for both extracellular and intracellular markers.
Data analyses were performed with the GraphPad Prism version 6.01 (GraphPad Software, Inc.) and the R statistical software version 3.4.0 (R Foundation for Statistical Computing). The demographics and clinical characteristics of the study participants were compared among the 3 study groups using Chi square test for categorical variables, Kruskal–Wallis or One-way ANOVA for continuous variables, Mann–Whitney U test and Wilcoxon-Signed Rank Test for paired comparisons for data that were not normally distributed. For comparing the markers of T cells among the 3 study populations, the Kruskal–Wallis test was used with a Dunn’s post hoc test or a Bonferroni correction for multiple comparisons where necessary. Spearman’s rank correlation was used to determine associations between markers. Support vector machine model, a supervised machine-learning algorithm was used to predict disease status. Statistical significance was set at P-values < 0.05.
Characteristics of the study population
Venous blood samples were obtained from 57 children including 18 with asymptomatic P. falciparum infections, 22 with symptomatic malaria, and 17 with no P. falciparum parasites detected in blood by microscopy or rapid diagnostic test (Table 1). There was no statistically significant difference between the ages of children in the asymptomatic versus symptomatic groups. In contrast, the healthy controls were significantly older than the asymptomatic (P = 0.0404) and symptomatic children (P = 0.0123). Also, the mean haemoglobin levels in asymptomatic children were significantly higher compared to the symptomatic children (P = 0.0348). However, levels were comparable between the children in the control group and asymptomatic or symptomatic groups. Total leukocyte counts were significantly higher in the asymptomatic children compared to symptomatic children (P = 0.0478) but comparable to controls. Even though the median lymphocyte counts did not differ significantly amongst the groups, lower levels were found in the symptomatic group than in the asymptomatic and control groups. Also, platelet levels decreased with the severity of P. falciparum infections. The median platelet counts in the symptomatic children were significantly lower than in the asymptomatic (P = 0.0029) and control (P < 0.0001) groups. Children in the asymptomatic group had statistically similar platelet counts as the control group. Parasitaemia levels were significantly lower in asymptomatic children compared to children with symptomatic infection (P = 0.0009).
Decreased levels of regulatory T cells in asymptomatic Plasmodium falciparum infections
To investigate if there are any differences between the P. falciparum-infected group and healthy controls with respect to T cell regulation, the levels of Treg populations in the 3 study groups were determined. Here, Treg populations were classified as CD3+, CD4+, CD25+ and FoxP3+ (Fig. 1a).
For the peripheral blood mononuclear cells (PBMCs) analysed directly without stimulation (ex vivo), it was observed that Tregs had a lower frequency in the asymptomatic children compared to the symptomatic children (P = 0.0065), but levels were comparable between asymptomatic and control groups (P > 0.05). Also, the Treg frequency in the symptomatic children was higher than in the controls (P = 0.0209, Fig. 1b). This trend remained the same after the cells were stimulated with iRBCs in vitro; lower levels of Tregs were found in the asymptomatic children than in the symptomatic children (P = 0.0394), while levels were comparable to the controls. Similarly, levels in the symptomatic children were higher than in the controls (P = 0.0391, Fig. 1b).
Furthermore, the levels of activated Tregs based on the expression of CTLA4, an immunosuppressive marker that inhibits activation of immune cells by direct contact, were determined. The levels of CTLA4+ Tregs differed significantly across the study populations (P = 0.0017). The levels of CTLA4+ Tregs in children with asymptomatic malaria were significantly lower than in those with clinical malaria (P = 0.0174, Fig. 1c) but comparable with the control group. However, levels of CTLA4+ Tregs in the symptomatic group were significantly higher than in the control group (P = 0.0034). In addition, after iRBC stimulation, CTLA-4+ Treg levels remained significantly lower in the asymptomatic group compared to the symptomatic group (P = 0.0493) but were comparable to levels observed in healthy controls (P = 0.5457, Fig. 1c).
Decreased expression of CD69 activation marker on T cells in asymptomatic Plasmodium falciparum infections before infected red blood cell stimulation
With the observed levels of Tregs being lower in the asymptomatic children compared to symptomatic children, the extent of cellular activation was measured to determine if they may differ across the study groups. The expression of the CD69 activation marker on both CD4+ and CD8+ T cell sub-sets before in vitro stimulation was investigated (Fig. 2a). Children with asymptomatic malaria had significantly lower levels of CD69+ expression on CD4+ T cells compared to children with symptomatic disease (P = 0.0016) but had comparable levels with the controls (P > 0.05, Fig. 2b). In addition, children with symptomatic malaria had a higher level of the CD4+CD69+ T cells than the controls (P = 0.0068, Fig. 2b). This trend was the same for the CD8+CD69+ T cells.
The pattern of expression of CD25 on T cells among symptomatic, asymptomatic Plasmodium falciparum infections and healthy controls before infected red blood cell stimulation
The expression levels of CD25, a late activation marker, on CD4+ and CD8+ T cells were determined (Fig. 2a). Except for CD8+CD25+CD69− T cells, levels of CD25 were not significantly different between asymptomatic and symptomatic children. There was no significant difference in the expression of CD25 on CD4+ T cells across the study populations (P = 0.4971, Fig. 3a). However, for CD8+ T cells, the expression of CD25 was significantly lower in the asymptomatic group compared to the symptomatic children (P = 0.0257), whereas levels between the asymptomatic and control groups were comparable (Fig. 3a).
CD25+FOXP3− T cells have been classified as activated effector Th 1 cells capable of secreting effector cytokines, such as IFNγ (interferon gamma), TNF (tumour necrosis factor) and IL-10 (interleukin-10). Therefore, the ex vivo expression of these markers was compared across the study groups. No significant difference was observed in the expression of CD25+FOXP3− on either CD4+ or CD8+ T cell sub-sets between asymptomatic and symptomatic children. However, the levels of CD25+FOXP3− on CD4+ T cells were significantly lower in the healthy controls when compared to the asymptomatic (P = 0.0063) or symptomatic children (P = 0.0024). In addition, no significant difference was observed in the expression of CD8+CD25+FOXP3− T cells across the study groups (P = 0.1192, Fig. 3b).
Decreased expression of CD25+CD69+ T cell activation markers during asymptomatic Plasmodium falciparum infections before infected red blood cell stimulation
The expression of CD69 activation marker on both CD4+ and CD8+ T cell subsets before in vitro stimulation was investigated in the three study groups (Fig. 2a). For the PBMCs analysed ex vivo, CD4+ and CD8+ T cells expressing both CD25 and CD69 were higher in the symptomatic when compared to the asymptomatic group (P = 0.016 and P = 0.0062) and healthy controls (P = 0.047 and P = 0.0232), respectively (Fig. 3c). However, no significant difference was observed between the asymptomatic group and controls (P > 0.05) for both T cell sub-sets (Fig. 3c).
Increased expression of activation marker on T cells in asymptomatic infections after infected red blood cell stimulation
When PBMCs were stimulated in vitro with iRBCs, levels of activated CD4+CD69+ T cells in the asymptomatic children increased significantly above those found in the symptomatic children (P = 0.0002) and controls (P = 0.0008, Fig. 4a). Levels of CD4+CD69+ T cells did not differ significantly between symptomatic children and controls. Higher expression of CD8+CD69+ cells was also observed in the asymptomatic cohort compared to both symptomatic children (P = 0.0057) and controls (P = 0.0054) (Fig. 4a). As was observed in the CD4+ T cell compartment, levels of CD8+CD69+ T cells did not differ significantly between symptomatic children and controls (Fig. 4a).
Also, no significant difference was found in the expression of CD25+CD69− T cells on any of the T cell sub-sets across the study groups (Fig. 4b). Levels of CD25+FOXP3− activated effector T cells were increased in the asymptomatic children compared to symptomatic and healthy controls (Fig. 4c). Increased levels of the CD4+CD25+FOXP3− activation marker were found in the asymptomatic group compared to the symptomatic (P = 0.035) and control (P = 0.0007) groups. Likewise, CD8+CD25+FOXP3− activated T cells were significantly increased in the asymptomatic group compared to the symptomatic (P = 0.0208) and control (P < 0.0001) groups (Fig. 4c). In addition, a significant increase in levels of double-positive CD4+CD25+CD69+ T cells were observed in the asymptomatic children compared to the symptomatic children (P = 0.035) and controls (P = 0.0025, Fig. 4d). Likewise, higher expression of CD8+CD25+CD69+ cells was observed in the asymptomatic cohort when compared to the healthy controls (P = 0.023) but not the symptomatic children (P > 0.05, Fig. 4d).
Cellular activation and Treg frequency govern parasitaemia and disease status
Correlations between the 24 considered T cell phenotypes (including the pre- and post-iRBC stimulation levels of Tregs) and parasite control (as measured by parasitaemia levels) were investigated. After applying a Bonferroni correction for multiple comparisons, significant positive correlations were found between parasitaemia and the levels of both CD8+CD69+ (r = 0.4128658, P = 0.0016) and CD8+CD25+CD69+ (r = 0.4070214, P = 0.0018) T cells measured before iRBC stimulation, and the levels of both CD4+CD25+Foxp3+ (r = 0.4772815, P = 0.0002) and CD8+CD25+Foxp3+ (r = 0.4772714, P = 0.0003) T cells measured after stimulation. Strikingly, levels of these four T cell phenotypes together accounted for 68% of the variation in parasitaemia observed in asymptomatic and symptomatic children (Additional files 2, 3).
Machine learning was used to determine whether the levels of these four T cell phenotypes alone could be used to predict disease status in infected children. A model based on a support vector machine was fitted to the levels of the four T cell phenotypes measured in a sub-set of the infected children and then used to predict disease severity in the remaining children. Using a 5-fold cross-validation analysis to prevent overfitting, it was found that the model accurately distinguishes between asymptomatic and symptomatic children, with a sensitivity of 86%, a specificity of 94%, and an area under the receiver-operator-characteristic curve (AUC) of 90% (Fig. 5). Together, the results suggest that expression levels of the considered regulatory and activation markers determine most of the individual variation in parasitaemia and predict disease status in asymptomatic and symptomatic P. falciparum infections.
The aim of this study was to investigate the frequency of activated Tregs and T cell early and late activation markers during P. falciparum infections, and the correlations between these and levels of parasitaemia. It was observed that asymptomatic infections are associated with lower levels of Tregs with reduced Treg activation, and reduced expression of T cell activation markers compared to symptomatic infections. Also, T cells from asymptomatic P. falciparum-infected children were more responsive to iRBC stimulation compared to cells from symptomatic children. Importantly, the measured variations in regulatory and activation marker levels explained most (68%) of the variation in parasitaemia observed in asymptomatic and symptomatic infections. These results indicate that in contrast to children with symptomatic malaria, there seems to be appropriate levels of immune regulation and activation in children with asymptomatic malaria, which favor the control of parasitaemia. Another, non-mutually exclusive possibility not ruled out by the analyses is that asymptomatic children might have higher levels of protective antibodies compared to symptomatic children, which might contribute to the observed differences in parasitaemia.
Previous data have shown that malaria-exposed individuals can harbour infection without clinical symptoms, implying that there is some level of immune restriction on parasite replication . Increased levels of Tregs have been associated with higher parasitaemia [10, 11] and delayed parasite clearance  as well as the development of clinical disease [15, 32, 33]. In this study, it was found that the level of Tregs is higher in children with clinical malaria compared to children with asymptomatic infections and healthy controls. This supports findings from other studies which have also associated increased Treg frequencies with symptomatic malaria infections [9, 23]. Also, the significant increase in the Treg frequency which was observed in the symptomatic children after iRBC stimulation may indicate that during clinical malaria Tregs from the pre-clinical state are expanded or being induced.
The low levels of Tregs observed in the asymptomatic children corroborates the findings of Boyle et al.  who identified lower levels of Tregs in children with asymptomatic infections. This was interesting since in another previous study by Jangpatarapongsa et al.  they also identified lower amounts of Treg cytokines in individuals with asymptomatic Plasmodium vivax infections, suggesting there is less Treg activation in individuals with asymptomatic Plasmodium infections. This supports the view that lower levels of Tregs may be associated with a decreased risk of developing clinical disease and possibly an increased likelihood of developing immunity to malaria.
It has recently been shown that Tregs expressing CTLA-4 in murine models of malaria interfere with the acquisition of long-term immunity to malaria infections . The increase in CTLA-4 in Tregs observed in individuals with P. falciparum infections compared to uninfected controls could reflect their direct role in controlling immune responses during human malaria infections. Also, the increased expression of CTLA-4 on Tregs in the symptomatic children suggests that immune regulation associated with clinical malaria may affect cellular activation, consequently, affecting the downstream development of anti-malaria immunity.
Importantly, persistent immune activation has been described as a major factor in predicting disease with increased levels of activation being associated with clinical disease progression [34,35,36]. Resting T cells are identified phenotypically by the absence of CD25/CD69 markers . In this study, activated T cells were classified by the expression of CD25+/CD69+ markers. A significant increase in immune activation in the CD4 and CD8 T cells was observed in clinical malaria. This is in line with a previous study that observed increased immune activation during clinical malaria infections . However, it should be noted that the increased activation in symptomatic children may not directly connote an effective T cell response since cytokine profiles were not measured.
In contrast, in the asymptomatic children, it was found that fewer cells expressed both activation markers on either CD4 or CD8 T cells indicating reduced cellular activation when compared to children with symptomatic malaria. A plausible interpretation of these results is that lower immune suppression by Tregs in asymptomatic children leads to more effector T cell activation and greater parasite control, which in turn feeds back to reduce T cell activation. Conversely, higher immune suppression in symptomatic children might limit parasite control leading to higher levels of parasitaemia and T cell activation. This is in line with the observation that P. falciparum activates the immune system in a dose-dependent manner . In addition, the lack of symptoms, lower levels of immune activation, and lower parasitaemia in the asymptomatic children might also result from higher levels of parasite-specific antibodies that reduce parasitaemia levels below the threshold required to induce a T cell response. Additional research is needed to elucidate these hypotheses.
It has been shown that asymptomatic children maintain levels of CD4+CD25+FOXP3- effector T cells that co-produce IFNγ, TNF and IL-10, describing these cells as self-regulatory [9, 40]. Even though lower levels of Tregs and activated Tregs were observed in the asymptomatic children, CD4+CD25+FOXP3− T cells were not significantly different between the asymptomatic and symptomatic children. This may suggest that during asymptomatic malaria, restriction of parasite replication and inflammation may be mediated by these self-regulating effector T cells.
Unfortunately, this study had a number of limitations since a longitudinal study could not be conducted to determine if any of the asymptomatic cohorts may develop clinical disease because they were treated when diagnosed. Consequently, the possibility that the immune dynamics observed reflect changes that occur during the natural course of P. falciparum infections could not be ruled out. In addition, because parasitaemia was determined by microscopy, it was not possible to determine conclusively that none of the healthy cohort had sub-microscopic infection. It was also, not possible to evaluate the humoral response in the study population to determine its contribution to the immune dynamics observed.
The study shows evidence that Tregs are lower and associated with reduced Treg activation in children with asymptomatic P. falciparum infections, which corresponds to reduce cellular activation and lower levels of parasitaemia. Also, the greater expansion of activation markers after iRBC stimulation in asymptomatic children compared to symptomatic children suggests that the former children harbour a larger latent repertoire of parasite-responsive T cells. Alternatively, this observation could reflect less Treg-mediated suppression of T cell activation in cells from asymptomatic children. Together, these data support the view that the dynamics of T cell regulation and activation may contribute to the acquisition of anti-parasite and/or anti-disease immunity to malaria. Insights into these dynamics might inform the development of malaria vaccines that induce appropriate levels of cellular activation and regulation as well as optimal control of parasitaemia and disease.
regulatory T cells
cytotoxic T-cell lymphocyte antigen 4
peripheral blood mononuclear cells
infected red blood cells
uninfected red blood cells
tumour necrosis factor
Gonçalves BP, Huang C-Y, Morrison R, Holte S, Kabyemela E, Prevots DR, et al. Parasite burden and severity of malaria in Tanzanian children. N Engl J Med. 2014;370:1799–808.
Sissoko MS, Healy SA, Katile A, Omaswa F, Zaidi I, Gabriel EE, et al. Safety and efficacy of PfSPZ vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial. Lancet Infect Dis. 2017;17:498–509.
White MT, Verity R, Griffin JT, Asante KP, Owusu-Agyei S, Greenwood B, et al. Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect Dis. 2015;15:1450–8.
Osier FH, Feng G, Boyle MJ, Langer C, Zhou J, Richards JS, et al. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria. BMC Med. 2014;12:108.
Portugal S, Pierce SK, Crompton PD. Young lives lost as B cells falter: what we are learning about antibody responses in malaria. J Immunol. 2013;190:3039–46.
McCallum FJ, Persson KE, Mugyenyi CK, Fowkes FJ, Simpson JA, Richards JS, et al. Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum. PLoS ONE. 2008;3:e3571.
Jangpatarapongsa K, Chootong P, Sattabongkot J, Chotivanich K, Sirichaisinthop J, Tungpradabkul S, et al. Plasmodium vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur J Immunol. 2008;38:2697–705.
Kho S, Marfurt J, Noviyanti R, Kusuma A, Piera KA, Burdam FH, et al. Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection. Infect Immun. 2015;83:3224–32.
Walther M, Jeffries D, Finney OC, Njie M, Ebonyi A, Deininger S, et al. Distinct roles for FOXP3+ and FOXP3−CD4+ T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog. 2009;5:e1000364.
Minigo G, Woodberry T, Piera KA, Salwati E, Tjitra E, Kenangalem E, et al. Parasite-dependent expansion of TNF receptor II—positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog. 2009;5:e1000402.
Walther M, Tongren JE, Andrews L, Korbel D, King E, Fletcher H, et al. Upregulation of TGF-β, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity. 2005;23:287–96.
Finney OC, Riley EM, Walther M. Regulatory T cells in malaria—friend or foe? Trends Immunol. 2010;31:63–70.
Kurup SP, Obeng-Adjei N, Anthony SM, Traore B, Doumbo OK, Butler NS, et al. Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4. Nat Med. 2017;23:1220–5.
Wammes LJ, Wiria AE, Toenhake CG, Hamid F, Liu KY, Suryani H, et al. Asymptomatic plasmodial infection is associated with increased tumor necrosis factor receptor II—expressing regulatory t cells and suppressed type 2 immune responses. J Infect Dis. 2013;207:1590–9.
Todryk SM, Walther M, Bejon P, Hutchings C, Thompson FM, Urban BC, et al. Multiple functions of human T cells generated by experimental malaria challenge. Eur J Immunol. 2009;39:3042–51.
Couper KN, Blount DG, Wilson MS, Hafalla JC, Belkaid Y, Kamanaka M, et al. IL-10 from CD4+CD25−Foxp3−CD127− adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog. 2008;4:e1000004.
Torres KJ, Villasis E, Bendezú J, Chauca J, Vinetz JM, Gamboa D. Relationship of regulatory T cells to Plasmodium falciparum malaria symptomatology in a hypoendemic region. Malar J. 2014;13:108.
Gonçalves RM, Salmazi KC, Santos BA, Bastos MS, Rocha SC, Boscardin SB, et al. CD4+CD25+Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses? Infect Immun. 2010;78:4763–72.
Cambos M, Belanger B, Jacques A, Roulet A, Scorza T. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion. Int J Parasitol. 2008;38:229–38.
Hisaeda H, Tetsutani K, Imai T, Moriya C, Tu L, Hamano S, et al. Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells. J Immunol. 2008;180:2496–503.
Vigário AM, Gorgette O, Dujardin HC, Cruz T, Cazenave P-A, Six A, et al. Regulatory CD4+CD25+Foxp3+ T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria. Int J Parasitol. 2007;37:963–73.
Torcia MG, Santarlasci V, Cosmi L, Clemente A, Maggi L, Mangano VD, et al. Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria. Proc Natl Acad Sci USA. 2008;105:646–51.
Hansen DS, Schofield L. Natural regulatory T cells in malaria: host or parasite allies? PLoS Pathog. 2010;6:e1000771.
Burel JG, Apte SH, Groves PL, Boyle MJ, Langer C, Beeson JG, et al. Dichotomous miR expression and immune responses following primary blood-stage malaria. JCI Insight. 2017;2:e93434.
Sancho D, Gómez M, Sánchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 2005;26:136–40.
Ziegler SF, Ramsdell F, Hjerrild KA, Armitage RJ, Grabstein KH, Hennen KB, et al. Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur J Immunol. 1993;23:1643–8.
Ziegler SF, Ramsdell F, Alderson MR. The activation antigen CD69. Stem Cells. 1994;12:456–65.
Clausen J, Vergeiner B, Enk M, Petzer AL, Gastl G, Gunsilius E. Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Immunobiol. 2003;207:85–93.
Mardiney M III, Brown MR, Fleisher TA. Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen-or antigen-induced proliferative capacity in normals. Cytometry A. 1996;26:305–10.
Ononye NC. Characterization of malaria transmission and insecticide susceptibility status of Anopheles Gambiae Sensu Lato Gilles (Diptera: Culicidae). In: Shai-Osudoku District of Southern Ghana. University of Ghana; 2015.
Musah A. Effectiveness of the National Malaria Control Programme in Akwapim South Municipality. University of Ghana; 2013.
Boyle MJ, Jagannathan P, Farrington LA, Eccles-James I, Wamala S, McIntyre TI, et al. Decline of FoxP3+ regulatory CD4 T cells in peripheral blood of children heavily exposed to malaria. PLoS Pathog. 2015;11:e1005041.
Semple PL, Binder AB, Davids M, Maredza A, van Zyl-Smit RN, Dheda K. Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis. Am J Respir Crit Care Med. 2013;187:1249–58.
Karim R, Mack WJ, Stiller T, Operskalski E, Frederick T, Landay A, et al. Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach. AIDS. 2013;27:1473–81.
Fletcher HA, Snowden MA, Landry B, Rida W, Satti I, Harris SA, et al. T-cell activation is an immune correlate of risk in BCG vaccinated infants. Nat Commun. 2016;7:11290.
Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 2003;17:1881–8.
Baldauf H-M, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, et al. SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. Nat Med. 2012;18:1682–9.
Worku S, Troye-Blomberg M, Christensson B, Björkman A, Fehniger T. Activation of T cells in the blood of patients with acute malaria: proliferative activity as indicated by Ki-67 expression. Scand J Immunol. 2001;53:296–301.
Finney OC, Lawrence E, Gray AP, Njie M, Riley EM, Walther M. Freeze-thaw lysates of Plasmodium falciparum-infected red blood cells induce differentiation of functionally competent regulatory T cells from memory T cells. Eur J Immunol. 2012;42:1767–77.
Portugal S, Moebius J, Skinner J, Doumbo S, Doumtabe D, Kone Y, et al. Exposure-dependent control of malaria-induced inflammation in children. PLoS Pathog. 2014;10:e1004079.
AF and WN conceived the idea, designed the experiments. WN, MFO and KAK supervised the work. AF performed the experiments in the study. BT assisted in the experiment. AF, KAK, MFO and WN wrote the paper. All authors read and approved the final manuscript.
The authors thank the parents, guardians and children who participated in this study. We are also grateful to the Directors and Clinical staff at the Shai-Osudoku Health Directorate in the Shai-Osudoku district of Greater Accra region, John Tetteh, Sophia Ampah, Jones Amponsah, Emmanuel K. Dickson and Alex Danso-Coffie of the Immunology Department, NMIMR for their technical support, and the University of Ghana’s Malaria Centre of Excellence.
The authors declare that they have no competing interests.
Availability of data and materials
The datasets generated and/or analyzed during the current study are available from the corresponding author(s) on reasonable request.
Consent for publication
The authors have read and agreed to the content of this manuscript and its publication upon acceptance.
Ethics approval and consent to participate
Ethical approval was obtained from the ethics committee of the Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana. Participation was voluntary and written informed consent and assent were obtained from parents/guardians and the children respectively.
Augustina Frimpong is supported by a Ph.D. fellowship from a World Bank African Centres of Excellence Grant (ACE02-WACCBIP: Awandare) and the International Development Research Center research grant from the African Institute for Mathematical Sciences, Ghana, the L’Oreal-UNESCO for Women in Science Grant, the Carnegie Corporation of New York and the University of Ghana BanGA Ph.D. Research Grant.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Frimpong, A., Kusi, K.A., Tornyigah, B. et al. Characterization of T cell activation and regulation in children with asymptomatic Plasmodium falciparum infection. Malar J 17, 263 (2018). https://doi.org/10.1186/s12936-018-2410-6
- Regulatory T-cells
- T-cell activation